Pharmiweb ChannelsAll | PharmaCo | Clinical Research | R&D/BioTech | Sales/Mktg | Healthcare | Recruitment | Pharmacy | Medical Comms RSS Feed RSS Feeds


Press Release

Esperite N.V. (ESP) : Update to the market on the publication of the Annual Report 2017.

Posted on: 31 Aug 18

Amsterdam, The Netherlands - 31 August 2018

Esperite NV announced mid-August that the Company had solved the technical issues that caused the delay regarding the publication of the Annual Report 2017. The departments involved made significant progress to finalize the Annual Report 2017.

Esperite continues to strive to publish its Annual Report 2017 and Half year Results 2018 as promptly as practicable.

ESPERITE group, listed at Euronext Amsterdam and Paris, is a leading international company in regenerative and precision medicine founded in 2000.
To learn more about the ESPERITE Group, or to book an interview with CEO Frédéric Amar: +31 575 548 998 - or visit the websites at and


This press release contains inside information as referred to in article 7 paragraph 1 of Regulation (EU) 596/2014 (Market Abuse Regulation).



Last updated on: 31/08/2018

Site Map | Privacy & Security | Cookies | Terms and Conditions is Europe's leading industry-sponsored portal for the Pharmaceutical sector, providing the latest jobs, news, features and events listings.
The information provided on is designed to support, not replace, the relationship that exists between a patient/site visitor and his/her physician.